Mutation Analysis of PAH Gene in Phenylketonuria Patients from the North of Iran: Identification of Three Novel Pathogenic Variants

Hossein Jalali, Daniel Zamanfar, Muhammad Amirzadegan, Farshide Ghadami, Mahan Mahdavi, Mohammad Reza Mahdavi

Abstract


Background: There are more than 1100 different pathogenic variants in the phenylalanine hydroxylase (PAH) gene that are responsible for phenylketonuria (PKU) diseases, and the spectrum of these mutations varies in different ethnic groups. The aim of the present study was to identify the frequency of pathogenic variants in all 13 exons of the PAH gene among patients with PKU in Mazandaran and Golestan provinces in the north of Iran. Methods: Forty unrelated PKU patients from Mazandaran and Golestan provinces were enrolled in the study. Genomic DNA was extracted from leukocytes using a Qiagen DNA extraction kit and polymerase chain reaction – restriction fragment length polymorphism (PCR‑RFLP), and Sanger sequencing methods were applied to detect the variants. In the case of new variants, the InterVar online tool (PMID: 28132688) was used to classify the variants. Results: Twenty‑one different pathogenic variants were observed among the 40 investigated patients. The c.106611G>A variant had the highest frequency (27.5%) in the region, and the c.168+5G>C, c.473G>A, and c.782 G>A variants were the other most frequent mutations with allelic frequencies of 7.5, 5, and 5%, respectively. Three novel pathogenic variants including c.773T>G, c.878 T>C, and c. 1245del variants were observed among the investigated patients. Conclusions: The introduction of pathogenic variants in the PAH gene in each ethnic group provides valuable data regarding the understanding of the pathogenesis of the disease and can be helpful for prenatal diagnosis programs.

 

International Journal of Preventive Medicine 15():22, April 2024. | DOI: 10.4103/ijpvm.ijpvm_50_23

Corresponding Author: Dr. Mohammad Reza Mahdavi

E‑mail: Mahdavi899@gmail.com

You can also search for this author in: PubMed Google Scholar


Keywords


Mutation, phenylalanine hydroxylase, phenylketonuria

Full Text:

PDF

References


Hillert A, Anikster Y, Belanger‑Quintana A, Burlina A, Burton BK,

Carducci C, et al. The genetic landscape and epidemiology of

phenylketonuria. Am J Hum Genet 2020;107:234‑50.

Waters PJ. How PAH gene mutations cause

hyper‑phenylalaninemia and why mechanism matters: Insights

from in vitro expression. Hum Mutat 2003;21:357‑69.

Blau N, Van Spronsen FJ, Levy HL. Phenylketonuria. Lancet

;376:1417‑27.

De Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, Van Spronsen FJ.

Pathogenesis of cognitive dysfunction in phenylketonuria: Review

of hypotheses. Mol Genet Metab 2010;99(Suppl 1):S86‑9.

Scriver CR. The PAH gene, phenylketonuria, and a paradigm

shift. Hum Mutat 2007;28:831‑45.

Ozalp I, Coskun T, Tokol S, Demircin G, Mönch E. Inherited

metabolic disorders in Turkey. J Inherit Metab Dis 1990;13:732‑8.

Gundorova P, Zinchenko RA, Kuznetsova IA, Bliznetz EA,

Stepanova AA, Polyakov AV. Molecular‑genetic causes for the

high frequency of phenylketonuria in the population from the

North Caucasus. PLoS One 2018;13:e0201489.

Shokri M, Karimi P, Zamanifar H, Kazemi F, Badfar G, Azami M.

Phenylketonuria screening in Iranian newborns: A systematic

review and meta‑analysis. BMC Pediatr 2020;20:352.

Senemar S, Ganjekarimi AH, Tarami B, Bazrgar M. The

prevalence and clinical study of galactosemia disease in a pilot

screening program of neonates, Southern Iran. Iran J Public

Health 2011;40:99‑104.

Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M.

Epidemiological and clinical study of Phenylketonuria (PKU)

disease in the National Screening Program of Neonates, Fars

province, Southern Iran. Iran J Public Health 2009;38:58‑64.

Blau N. Genetics of phenylketonuria: Then and now. Hum Mutat

;37:508‑15.

Blau N, Shen N, Carducci C. Molecular genetics and diagnosis

of phenylketonuria: State of the art. Expert Rev Mol Diagn

;14:655‑71.

Zamanfar D, Jalali H, Mahdavi MR, Maadanisani M, Zaeri H,

Asadpoor E. Investigation of five common mutations on

phenylalanine hydroxylase gene of phenylketonuria patients from

two provinces in north of Iran. Int J Prev Med 2017;8:89.

Zare‑Karizi S, Hosseini‑Mazinani SM, Khazaei‑Koohpar Z,

Seifati SM, Shahsavan‑Behboodi B, Akbari MT, et al. Mutation

spectrum of phenylketonuria in Iranian population. Mol Genet

Metab 2011;102:29‑32.

Elhawary NA, AlJahdali IA, Abumansour IS, Elhawary EN,

Gaboon N, Dandini M, et al. Genetic etiology and clinical

challenges of phenylketonuria. Hum Genomics 2022;16:22.

Alibakhshi R, Mohammadi A, Salari N, Khamooshian S,

Kazeminia M, Moradi K. Spectrum of PAH gene mutations

in 1547 phenylketonuria patients from Iran: A comprehensive

systematic review. Metab Brain Dis 2021;36:767‑80.

Nemati H, Yousefi SSK, Pourvatan N, Aparviz R, Farzaneh P,

Koohpar ZK, et al. Mutation analysis of phenylketonuria in the

north of Iran. Gene Rep 2021;24:101196.